1276 results about "Lumbricus" patented technology

The invention relates to traditional Chinese medical liquor for external use for treating cervical spondylosi, periomethritis, hyperosteogeny, sciatica, rheumatism, rheumatoid disease, arthritis, soft tissue contusion, etc. The traditional Chinese medical liquor is intended to solve a problem that unsatisfied effect for treating the said diseases. A formula contains: cassia twig, Chinese parsnip root, notopterygium root, dahurian angelica root, radix bupleuri, root of kudzu vine, levisticum, clematis root, Tripterygium wilfordii Hook f, bark of ash, menispermaceae, cibotium rhizome, rhizoma zingiberis, monkshood, common fennel fruit, pseudo-ginseng, Ligusticum wallichii, safflower, Peach Seed, lumbricus, white batryticated silkworm, musk, borneol, Radix Astragali, Psoralea corylifolia, camphor, white peony root, Chinese angelica, Curculigo orchioides, Strychnos nuxvomica, centipede, cyathula root, ophidian, buck grass, Asarum Herb, speranskia herb, radix aconiti, tarragon, Chinese prickly ash, radix aconiti kusnezoffii, ephedra stem, ground beetle, scorpion, eucommia, myrrh, frankincense, pinellia ternate, licorice, garlic and capsicum. The traditional Chinese medical liquor has advantages of good curative effect, and low toxic and side effect.

The invention relates to a traditional Chinese medicine for treating cardiac, cerebral and vascular diseases; the drug is composed of forty kinds of crude drugs by weight parts: milk veteh, salvia miltiorrhiza, root of common peony, ligusticum wallichii, lumbricus, sanguisuga, rhizoma acori graminei, polygala root, red ocher, oyster, angelica, the root of kudzu vine, arisaema cum bile and the like; the preparation method is that: (1) the crude drugs are prepared into water extract liquid; (2) the water extract liquid is prepared into oral liquid; (3)the water extract liquid obtained by the step (1) is dried, crushed, sieved, undersize material is extracted powder; (4) the extracted powder prepared by the step (3) is prepared into various dosage forms. The preparation method of crude powder is that: lime earth of the crude drugs is sieved, and then the crude drugs are crushed and sieved, the undersize material is taken out and is sterilized to be crude powder, and the crude powder is prepared into various dosage forms. The traditional Chinese medicine has the major functions of treating miocardial infarction and angina caused by coronary heart disease, high blood pressure and cerebral thrombosis, hemiplegia, cerebral infarction, cerebrovascular accident, sequel of apoplexy and other symptoms, and the medicine has obvious effect on headache, dizziness and heart cerebrovascular diseases caused by high blood pressure and cerebral circulation insufficiency.

The invention relates to the technical field of traditional Chinese medicines, and in particular to a traditional Chinese medicine unguent for promoting blood circulation to remove meridian obstruction and a preparing method of the traditional Chinese medicine unguent. The traditional Chinese medicine unguent for promoting blood circulation to remove meridian obstruction mainly comprises the following raw materials: drynaria rhizome, radix clematidis, pawpaw, notopterygium root, radix angelicae tuhuo, radix saposhnikoviae, ligusticum wallichii, garden balsam stem, lycopodium clavatum, radix dipsaci, medicinal cyathula root, safflower carthamus, eucommia ulmoides, angelica sinensis, cassia twig, the root of common peony, rheum officinale, asarum, frankincense, myrrh, monkshood, radix aconiti agrestis, acacia catechu, ephedra, ground beeltle, lumbricus, stir-baked squama manitis, scorpio, pseudo-ginseng, daemonorops draco and borneol. The traditional Chinese medicine unguent is scientific in formula, and has the effects of promoting circulation and removing stasis, clearing and activating the channels and collaterals, dispelling wind to eliminate dampness, relieving swelling and pains and promoting reunion of fractured bones. The traditional Chinese medicine unguent is used for treating diseases such as lumbar disc herniation, traumatic injuries, fractures, osteoproliferation, arthritis, numbness of limb and femoral head necrosis, untoward effects are avoided, the traditional Chinese medicine unguent is safe, free of toxic and side effects and rapid in effect taking, treating both manifestation and root causes of the diseases, has a wide application prospect and market potential; and the total effective rate reaches 100%.

The invention relates to a medicine for treating bronchitis and bronchial asthma suffered by children aging from three to seven, which is composed of Chinese medicine decoction and acupuncture point injection medicament. The active ingredients of the oral Chinese medicine decoction are composed of various Chinese herbal medicines of roast ephedra, schisandra chinensis, American ginseng, a gecko, zaocys dhumnade, morinda officinalis, lumbricus, semen ginkgo, semen brassicae, semen lepidii, radix pseudostellariae, ramulus cinnamomi, radix paeoniae alba, radix rehmanniae praeparata, fructus psoraleae, radix achyranthis bidentatae, lycium chinense, black ants, poria cocos, largehead atractylodes rhizome, Chinese yam, scorpio, saposhnidoviae radix, cortex magnoliae officinalis, ganoderma lucidum, blackberry lily, Semen cuscutae, cark plum fruit, roast cortex mori radicis, roast flos farfarae, roast radix stemonae, lily, fried almond, tendril-leaved fritillary bulb and the like. The acupuncture point injection medicament is one of nucleotide and casein, placenta tissue fluid or astragalus injection. The medicine can treat both principal and secondary aspects of diseases, perform dialectical therapy, increase immunity of the organism and enable the functions of the damaged lungs, spleens, kidneys and hearts to recover, and has the advantages and effects of high curative rate and no relapse.

The invention relates to a traditional Chinese medicine composition for treating rheumatic bone diseases. The composition is prepared from the following raw materials by weight: radix stephaniae tetrandrae, angelica sinensis, loranthus parasiticus, scorpio, cortex acanthopanacis, polygonum multiflorum, myrrh, radix achyranthis bidentatae, rhizoma atractylodis macrocephalae, homalomena occulta, rhizoma cibotii, cortex illicii, lumbricus, elecampane, rhizoma drynariae, fructus lycii, rhizoma arisaematis, polygala tenuifolia, pericarpium citri reticulatae, loose knots, pawpaw, rehmannia glutinosa, akebiaquinata, centipede, Chinese parsnip roots, eucommia ulmoides, radix angelicae, radix dipsaci, radix clematidis and the like. The composition provided by the invention has the effects of dispelling wind and eliminating dampness, relaxing tendons and activating collaterals, promoting blood circulation to remove blood stasis and relieving swelling and pains, has a remarkable curative effect on rheumatism, rheumatoid arthritis and ischialgia, and is high in cure rate, safe and convenient and free from toxic and side effects. The situation that in the prior art, the medicine for treating rheumatic bone diseases such as rheumatism and arthritis is great in dosage, long in course of treatment and low in cure rate is changed.

The invention discloses a Chinese medicine composition for treating orthopedic disorders and a preparation method thereof. The Chinese medicine composition comprises the following components: 140-160g of rhizoma drynariae, 90-110g of eucommia bark, 90-110g of teasel root, 90-110g of bidentate achyranthes root, 20-30g of frankincense, 20-30g of myrrha, 140-160g of the red-rooted salvia root, 40-60g of flos carthami, 90-110g of panax pseudoginseng, 90-110g of szechuan lovage rhizome, 10-20g of prepared common monkshood mother root, 10-20g of prepared radix aconiti kusnezoffii, 90-110g of Chinese clematis, 90-110g of fructus chaenomelis lagenariae, 140-160g of radix astragali, 90-110g of Chinese angelica, 140-160g of prepared rehmannia root, 90-110g of ground beeltle, 40-60g of scorpio, 40-60g of lumbricus, 90-110g of snake slough, 140-160g of radix curcumae, 15-30g rhizoma curcumae longae and 40-60g of liquoric root. The invention has the advantages of special formula, remarkable effect, simple preparation method and easiness in operation.

The invention provides a traditional Chinese medicine for treating hypertension. The traditional Chinese medicine is prepared from the following components in parts by weight: 20 parts of uncaria rhynchophylla, 20 parts of concha haliotidis, 15 parts of eucommia bark, 15 parts of kudzuvine root, 20 parts of cassia seed, 15 parts of tree peony bark, 10 parts of radix scutellariae, 10 parts of Chinese wolfberry root-bark, 15 parts of white peony root, 15 parts of bupleurum root, 10 parts of gastrodia tuber, 15 parts of achyranthes root, 15 parts of Chinese taxillus twig, 15 parts of lumbricus, 15 parts of motherwort and 15 parts of fleece-flower stem. The components are mixed and pulverized and then the pulverized mixture is packaged with small paper medicine bags. After being drunk, the traditional Chinese medicine is absorbed in body so as to reach treatment effect; and the traditional Chinese medicine has the advantages of no side effects and obvious treatment effect on hypertension,and is convenient in use.

The invention discloses a traditional Chinese medicine preparation for treating protrusion and hyperplasia of human cervical and lumbar vertebra, and belongs to the field of traditional Chinese medicines. The preparation is prepared from the following bulk drugs according to a gram weight ratio: 6 g of radix aconiti kusnezoffii preparata, 6 g of radix aconiti preparata, 15 g of lumbricus, 12 g of madder, 15 g of cassia seeds, 15 g of herba siegesbeckiae, 10 g of ophiopogon japonicas, 50 g of radix rehmanniae preparata, 15 g of alpinia oxyphylla, 15 g of gentiana macrophylla, 10 g of licorice, 15 g of alisma orientalis, 15 g of haw, 15 g of villous amomum fruit, 15 g of ligusticum wallichii, 15 g of hippocampus, 10 g of centipede, 10 g of scorpion, 20 g of gekko, 30 g of pseudo-ginseng, 20 g of phellodendron, 15 g of psoralea corylifolia, 30 g of speranskia tuberculata, 10 g of pyritum, 20 g of mollissima, 10 g of muscardine silkworm, 15 g of tortoiseshell, 30 g of ardisia gigantifolia, and the like. The bulk drugs are weighed for decoction, or weighed and immersed in wine, or weighed and mixed uniformly and grinded into powder for preparation of tablets or pills. The medicine has functions of relaxing sinews, activating collaterals, dispelling wind, eliminating dampness, activating blood, resolving stasis, dispersing nodules and repositioning. The effective rate reaches 98% and the curative rate reaches 95% or more.

The invention discloses a grapefruit tea beverage. The grapefruit tea beverage is characterized by being prepared from following raw materials in parts by weight: 25-28 parts of umbilicaria esculenta, 3-5 parts of polygonum multiflorum, 2-3 parts of rhizoma polygonati, 3-5 parts of mints, 1-3 parts of pseudo-ginseng, 2-4 parts of lumbricus, 2-3 parts of baphicacanthus cusia, 15-17 parts of grapefruit peels, 17-19 parts of grapefruit pulp, 19-20 parts of sweet potatoes, 16-18 parts of rice, 14-16 parts of beef livers, 17-20 parts of chives, 16-19 parts of lemons, 16-18 parts of bitter gourds, 4-6 parts of an auxiliary agent and suitable amount of water. The beverage provided by the invention has the effects of nourishing kidney and moistening lung, tonifying spleen and tonifying qi, resisting oxygen deficit, resisting fatigue, resisting aging, enhancing the immunologic function, enhancing the metabolism, lowering the blood glucose and strengthening the heart. The beverage has a relieving effect on drunken people and also has the effects of relaxing the bowels and ventilating on belly-bound people; the beverage is a healthy and green food and has a wide development and application prospect.

The invention relates to a traditional Chinese medicine for treating lung-spleen qi deficiency syndrome of chronic obstructive pulmonary disease (COPD), which is used for effectively solving the medication problem of COPD. The traditional Chinese medicine is prepared from the following bulk drugs: 12-20g of astragalus root, 12-20g of solomonseal, 6-12g of pilose asiabell root, 9-15g of rhizoma atractylodis macrocephalae, 9-15g of Tuckahoe, 6-12g of Thunberg fritillary bulb, 9-15g of lumbricus, 6-12g of officinal magnolia bark, 9-15g of dried tangerine peel, 6-12g of aster tataricus, 15-30g ofJapanese ardisia herb and 6-12g of epimedium. The preparation method of the traditional Chinese medicine comprises the following steps: mixing the rhizoma atractylodis macrocephalae with the dried tangerine peel, steaming and decocting with water, collecting volatile oil, and filtering water decoction obtained after steaming and decocting to obtain first decoction; refluxing the officinal magnolia bark, the aster tataricus and the Thunberg fritillary bulb with ethanol, filtering, recovering the ethanol and concentrating to obtain first extract; decocting dregs of the rhizoma atractylodis macrocephalae and the dried tangerine peel, dregs of the officinal magnolia bark, the aster tataricus and the Thunberg fritillary bulb as well as the astragalus root, the solomonseal, the pilose asiabell root, the lumbricus, the Japanese ardisia herb, the epimedium and the Tuckahoe with water, filtering the decoction, mixing the filtrate with the first decoction, and concentrating the mixed decoction to obtain second extract; mixing the second extract with the first extract, and adding dextrin to obtain first dry powder; grinding and mixing the volatile oil and dextrin, and drying to obtain seconddry powder; and evenly mixing the second dry powder with the first dry powder, and adding honey to form granules. The traditional Chinese medicine has a scientific formula, and is easy for production.

The invention provides a Chinese medicinal health product for treating chronic bronchitis. The Chinese medicinal health product is prepared from the following raw materials: 10 to 30 g of Rehmannia glutinosa, 10 to 20 g of Radix Ophiopogonis, 10 to 30 g of jujube, 15 to 30 g of Dioscorea Rhizome, 6 to 12 g of Chinese magnoliavine, 10 to 45 g of the root bark of a peony tree, 10 to 30 g of Rhizome Alismatis, 15 to 45 g of bitter apricot kernel, 30 to 60 g of hickory nuts, 15 to 45 g of ginger, 6 to 12 g of dried ginger, 15 to 30 g of safflower, 20 to 40 g of haw, 10 to 30 g of Rhizome Pinelliae Preparata, 10 to 20 g of magnolia cortex, 13 to 60 g of Fructus Forsythiae, 10 to 50 g of anemarrhena, 13 to 50 g of cape jasmine, 9 to 18 g of coix seeds, 10 to 30 g of balloonflower root, 10 to 50 g of cassia twig, 15 to 50 g of red sage root, 10 to 50 g of lumbricus, 10 to 50 g of Chinese angelica, 30 to 30 g of Radix Astragali, 10 to 20 g of gingko, 15 to 30 g of mulberry bark, 10 to 20 g of root of large-flowered skullcap, 6 to 12 g of licorice and 50 to 100 g of lactose.

A traditional Chinese medicine preparation for treating haemorrhoids comprises raw materials of, by weight, 20-30 parts of folium artemisiae argyi, 20-30 parts of ficus carica, 20-30 parts of dandelion, 14-22 parts of flos sophorae, 14-22 parts of rheum officinale, 14-22 parts of radix scutellariae, 12-18 parts of dried rehmannia root, 12-18 parts of phellodendron amurense, 12-18 parts of carthamus tinctorius, 9-15 parts of coptis chinensis, 9-15 parts of plantain herb, 9-15 parts of poria cocos, 5-9 parts of lumbricus, 5-9 parts of gentiana macrophylla, 5-9 parts of semen cassiae, 5-9 parts of akebiaquinata, 1-3 parts of borneol, 1-3 parts of mirabilite and 1-3 parts of camphor. The traditional Chinese medicine preparation for treating the haemorrhoids has the advantages of good curative effect, quickness in taking effect and less proneness to recurrence. Besides, the curative rate for treating the haemorrhoids reaches 100%.

The invention discloses a medicine composition for treating pains, which substantially comprises clematis root, Notopterygium root, pubescent angelica, root of gentian, radix saposhnikoviae, lumbricus, Drynaria fortunei, dried ginger, etc., 35 raw medicinal medicines. The medicine composition of the invention has stronger penetrating power, good transdermal adsorption, which can increase the temperature of a lesion location, improve the blood circulation, eliminate an inflammation, unblocking a dampness blocking channel and clearing off the congestion, has remarkable effects on rheumatism pains, cancer pains, stomach cold ache and all pains resulted from cervical and lumbar hyperosteogeny, traumatic injury, fascial strain, sciatica, scapulohumeral periarthritis, etc.

The invention relates to a drug for treating bronchitis and bronchial asthma of 7-15 year old children, which consists of oral Chinese medicinal decoction and acupuncture point injection. The active ingredients of Chinese medicinal decoction consists of a variety of Chinese herbal medicines, comprising Herba Ephedrae Praeparata, Schisandra chinensis, Astragalus mongholicus, American ginseng, Radix Pseudostellariae, a pair of gecko, Zaocys dhumnades, Morinda officinalis, Lumbricus, Herba Epimedii, Sinapis alba, Semen Descurainiae (Lepidium apetalum and / or Descurainia sophia), Ginkgo biloba seed, Ramulus Cinnamomi, Radix Paeoniae Alba, Radix Rehmanniae Praeparata, Fructus Psoralea, Achyranthes bidentata, Fructus Lycii, black ant, Poria cocos, Largehead Atractylodes Rhizome, Rhizoma Dioscoreae, Radix Glycyrrhizae, Scorpion, Divaricate saposhnikovia root, Belamcanda chinensis, Prunus mume, white mulberry root-bark, processed Tussilago farfara flower, Stemona Root, Lily Bulb, Semen Armeniacae Amarum, Ganoderma, Manchurian wildginger, Angelica sinensis, Cornus officinalis and Bombyx Batryticatus (Bombyx mori and / or Beauveria bassiana). The acupuncture point injection is one of nucleotide and casein, placenta tissue fluid and Astragalus mongholicus injection. The drug of the invention can treat both principal and secondary aspects of disease, determine the treatment based on differentiation of symptoms and signs, enhance body immunity, and recover the function of impaired lung, spleen, kidney and heart, and has the advantages of high cure rate and no recurrence.

The invention relates to a traditional Chinese medicinal composition for promoting the blood circulation and removing obstructions in channels. The traditional Chinese medicinal composition is prepared from the following raw materials, by weight, 15 parts of salvia miltiorrhiza, 12 parts of leech, 9 parts of Ligusticum wallichii, 9 parts of lumbricus, 10 parts of Radix Paeoniae Rubra, 5 parts of centipede, 6 parts of safflower, 4 parts of scorpion, 3 parts of Millettia dielsiana, 5 parts of Malayan pangolin, 8 parts of Chinese angelica, 6 parts of Radix Astragali, 5 parts of Achyranthes bidentata, 5 parts of rhizome of Whiteback Greenbrier, 4 parts of haw, and 6 parts of dandelion. The traditional Chinese medicinal composition of the invention is clinically applied to one hundred and twenty cases of venous thrombosis, and results show that: the traditional Chinese medicinal composition allows one-hundred and fourteen cases to be cured, is effective to five cases and is ineffective to zero case, so the cure rate is 95%, the effective rate is 4%, and the total effective rate is 100%. The traditional Chinese medicinal composition of the invention, which has the advantages of simple preparation, simultaneous treatment of principal and subordinate symptoms, no side effect and low price, has a wide application prospect.

The invention discloses a molecular identification method for a DNA bar code of lumbricus and a CO I sequence thereof. The method comprises the following steps: amplifying a sample CO I gene through polymerase chain reaction (PCR); verifying the PCR product through agarose gel and then sending to a biological sequencing company for sequencing; manually correcting and splicing sequence for the sequencing result; comparing with a public sequence; and if the homology of the gene sequence SEQ ID NO.1-NO.4 is above 99%, confirming a to-be-detected tissue as a source of pheretima aspergillum or Shanghai lumbricus. According to the invention, a reliable DNA molecular identification technique is adopted; the morphological identification for lumbricus varieties is not required; the lumbricus varieties and non-drug lumbricus varieties specified in Chinese Pharmacopoeia can be quickly and accurately identified; besides, the pheretima aspergillum and the Shanghai lumbricus can be further distinguished; the accuracy and the reliability can be enhanced; the safety of the lumbricus used as a medicinal material can be guaranteed.

The invention discloses a traditional Chinese medicine for treating cardio-cerebral vascular stagnation, which mainly consists of the following raw medicinal materials: monarch medicinal material: dried astragalus root; ministerial medicinal materials: Chinese angelica, Szechuan lovage rhizome, red paeony root, safflower, salvia miltiorrhiza and panax pseudoginseng; adjuvant medicinal materials: leech, lumbricus and Chinese polyphaga; and conductant medicinal materials: cassia twig and the root of bidentate achyranthes. All symptoms cured by using the traditional Chinese medicine are caused by qi deficiency and blood stasis; dried astragalus root is prized in the prescription for tonifying qi so as to flourish qi and promote blood circulation and removing stagnation to dredge collaterals and not hurt the vital essence, and is used as the monarch medicinal material matched with Chinese angelica to invigorate the circulation of blood under the combinational function of all the other medicinal materials, such that the stagnation is removed as well as good blood is not damaged. The Chinses angelica is used for invigorating the circulation of blood, removing stagnation, eliminating blood stasis and stopping bleeding with the help of the Szechuan lovage rhizome, the red paeony root, the safflower, the salvia miltiorrhiza and the panax pseudoginseng to serve as the ministerial medicinal materials together. The lumbricus, the leech and the Chinese polyphaga have the medicinal property of high walking ability and have the enhanced effects on clearing and activating channels and collaterals. The cassia twig is used for warming channels and promoting blood circulation. The root of bidentate achyranthes is used for removing the blood stasis, promoting the blood stasis and ensuring proper downward flow of the blood; therefore, qi and blood go up and down in order under the rising and declining functions alternatively.

The invention discloses a compound medicine for treating anaphylactic rhinitis-asthma syndrome and a preparation method and application thereof. The compound medicine comprises, by weight, of 60-300 parts of astragalus mongholicus, 20-100 parts of ephedra, 20-200 parts of divaricate saposhnikovia root, 20-200 parts of trichosanthes peel, 20-200 parts of allium macrostemon, 20-200 parts of rhizoma pinellinae praeparata, 12-120 parts of rhizoma zingiberis, 20-200 parts of almond, 20-200 parts of bighead atractylodes rhizome, 20-200 parts of cassia twig, 20-200 parts of poria cocos, 30-300 parts of radix paeoniae alba, 30-300 parts of lumbricus and 30-300 parts of honey-fried licorice root. The compound medicine for treating the anaphylactic rhinitis-asthma syndrome has the advantages of being good in curative effect, short in course of treatment, thorough in curative effect, free of side effect and the like. The preparation method for preparing the compound medicine for treating the anaphylactic rhinitis-asthma syndrome is simple, rapid, high in efficiency and easy to operate. Prepared mixture, troche, capsules, pellets and the like are convenient to carry and take.

The invention discloses a traditional Chinese medicine for treating apoplexy sequela, hypertension, hyperlipidemia and hyperviscosemia. The traditional Chinese medicine is prepared from the following bulk pharmaceutical chemicals as active ingredients in parts by weight: 100-120 parts of radix astragali seu hedysari, 10-15 parts of radix paeoniae rubra, 10-12 parts of herbs of false chinese swertia, 8-10 parts of rhizoma ligustici chuanxiong, 8-10 parts of semen persicae, 3-5 parts of flos carthami, 8-10 parts of lumbricus, 20-25 parts of radix salviae miltiorrhizae, 8-10 parts of hirudo, 10-15 parts of radix dipsaci, 12-15 parts of herba taxilli, 8-10 parts of cortex eucommiae, 28-30 parts of raw hawthorn, 4-5 parts of ramulus cinnamomi, 8-10 parts of bulbus allii macrostemonis, 12-15 parts of radix cyathulae, 18-20 parts of radix puerariae, 5-6 parts of scorpio, 28-30 parts of folium ginkgo, 25-30 parts of herba erigernotis, 8-10 parts of rhizoma alismatis, 28-30 parts of poria, 25-30 parts of semen ziziphi spinosae, 18-20 parts of semen cassiae, 18-20 parts of scorched medicated leaven and 10-15 parts of fructus ligustri lucidi. The traditional Chinese medicine can achieve the efficacies of invigorating qi and promoting blood circulation, promoting circulation and removing stasis, stimulating the menstruational flow and dissipating the phlegm, and tonifying the kidney and reducing the blood pressure, and is a first-choice medicament of the patients with apoplexy sequela, hypertension, hyperlipidemia and hyperviscosemia, and has obvious treatment effect.

The invention discloses a lumbricus polypeptide having anticoagulant and thrombolytic effects, and an enzymatic hydrolysis preparation method and an application thereof. The preparation method comprises the steps: cleaning and drying lumbricus dried bodies, and crushing into a powder; adding water, stirring, and centrifuging to obtain a protein precipitate; adding water to dissolve the protein, adding an alkaline protease with the ratio of the enzyme volume to the protein weight of 0.1-3 mL:100 g, and stirring; exterminating enzyme activity, adding trypsin with the ratio of the enzyme mass to the protein weight of 0.5-5 g:100 g, and stirring at the temperature of 25-60 DEG C; allowing the enzymatic hydrolysate to pass through an anion exchange column, collecting a part of eluate; and then passing through a macroporous adsorption resin, carrying out separation and purification, and collecting and drying to obtain a lumbricus anticoagulant peptide powder. A new source is added for high-activity anticoagulant active substances, the product activity is high, the preparation process is convenient and feasible, and the environment is protected; and the lumbricus polypeptide can be used as a raw material of foods for thrombosis prevention, thrombolysis and blood consistency reduction, is supplemented with lactose, mannitol and the like, and is made into a powder, a tablet, a capsule or an oral liquid.

The invention discloses a Chinese herbal medicine in the treatment of sequels of stroke and hemiplegia. The active pharmaceutical ingredient and weight ratios are demonstrated as follows: ground beetle 3-10g, astragalus 9-40g, codonopsis pilosula extract 10-30g, leonurus japonicus 9-30g, danshen root 9-15g, cyathula root 5-10g, peach kernel 5-10g, Jiang Chong 10-20g, safflower 5-9g, rhizoma ligustici wallichii 5-15g, scorpion 3-9g, lumbricus 5-10g, red peony root 6-12g, poria cocos 5-15g, chinese starjasmine stem 6-12g, stephania root 5-15g, coix seed 9-30g, crab apple 9-12g, eucommia bark 6-15g, combined spicebush root 5-10g, largehead atractylodes rhizome 6-15g, oriental waterplantain rhizome 6-15g, milettia reticulata 10-20g, gambir plant 5-12g, angelica sinensis 5-15g, turmeric rhizome 5-9g, cassia twig 3-9g, mulberry twig 10-20g, chinese clematis root 6-10g. That the sequels of stroke and hemiplegia are difficult to cure is because that muscle and joints are blocked by phlegm and blood stasis, which is caused by the deficiency of Qi. The prescription based on the pathogenesis, by righting and supporting the healthy energy, activating blood circulation to dissipate blood stasis, reducing phlegm and adjusting the balance of Yin and Yang, removes the causes of the illness and the total efficiency for the prescription is more than 98%.

The invention provides a plaster used for promoting generation of bone callus and treating fracture. The plaster can overcome limitation of conventional plasters in treatment of bone fractures and canincrease healing of the bones. The plaster is composed of: one or more of 10-20g of davallia mariesii, 5-15g of dipsacus asperoids and 10-20g of eucommia ulmoides; one or more of 10-20g of angelica sinensis, 10-20g of safflowers, 10-15g of pseudo-ginseng, 3-5g of pangolin, 2-7g of semen strychni, 10-20g of frankincense, 10-20g of myrrh, 5-10g of rhizoma sparganic, 5-10g of curcuma zedoaria and 5-15g of resina draconis; one or more of 10-15g of cloves and 10-15g of cinnamon; one or more of 5-10g of scorpions, 5-10g of arisaema consanguineum schott, 10-15g of lumbricus, 10-15g of centipede, 5-10g of raw radix aconiti, 5-10g of raw kusnezoff monkshood roots, 15-20g of common clubmoss herb and 15-20g of garden balsam stem; one or more of 15-20g of fresh ginger, 10-20g of nepeta cataria, 5-15gof angelica dahurica, 5-15g of notopterygium incisum and 5-15g of angelica pubescens roots; 10-15g of coptidis rhizoma, 10-15g of cortex phellodendri and 10-15g of gardenia; and 10-15g of rhubarb, 10-15g of sophora flavescens, 5-15g of honeycomb, 5-15g of snake slough, 5-15g of momordica cochinchinensis, 10-15g of magnolia officinalis and 5-10g of borneol. The plaster is prepared through conventional boiling processes, is reasonable in formula, is simple in preparation, is convenient to use, is portable, is low in cost and is significant in economic value and social value.

The invention discloses a plaster for treating pains in neck, shoulder, waist and legs. The plaster is made by mainly using Caulis Sinomenii, Aconitum kusnezoffii, Radix Aconiti, Boswellia carteri, myrrh, Viciaamoena Fisch, centipede, Ligusticum wallichii, Common Threewingnut Root, rhizoma corydalis, dahurian angelica root, ramulus mori, Semen Brassicae, scorpio, pawpaw, Zoacys Dhumnades, Radix Clematidis, dragon's blood, Mythic Fungus, Salvia miltiorrhiza, Rhizoma Cibotii, Panax Notoginseng, Incised Notopterygium, Radix Angelicae Pubescentis, medicine called Lingxian Divaricate Saposhnikovia Root, Radix Stephaniae Tetrandrae, Gentiana macrophylla, Rhizoma Drynariae, unprepared Polygonum multiflorum Thunb, tortoise shell, Nux Vomica, stir-baked squama manitis, lumbricus, rhizoma corydalis, borneol, Manchurian wildginger, Herbal Ephedrae, Cortex Acanthopanacis, safflower, camphor and rosin. The plaster is a special medicine for treating rheumatoid arthritis, traumatic injury, pains in neck, shoulder, waist and legs, and hyperosteogeny patients, is a traditional black plaster dosage form prepared with Chinese herbal medicines as raw materials, is a traditional Chinese medicinal plaster dosage form with definite therapeutic effects, and cures more than 100000 patients through the combination of traditional Chinese medicinal channel and collateral theory and local infected position application treatment.

A traditional Chinese medicine preparation for treating osteopathia comprises two groups of composing prescriptions, namely, the first group is as follows: a medicinal plaster A is prepared by centipede, scorpion, bungarus parvus, zaocys dhumnade, lumbricus, pangolin scales, ground beeltle, honeybee, black ants, moschus and venenum bufonis; the second group is as follows: a medicinal plaster B is prepared by semen strychni, aconitum brachypodum, flos daturae, radix aconiti, cortex cinnamomi, radix aconiti carmichaeli, panax notoginseng, ligusticum chuanxiong, radix dipsaci, radix cyathulae, fructus psoraleae, borneol, rhizoma homalomenae, radix clematidis, herba ephedra, herba asari cum radice, rhizoma sparganii, rhizoma curcumae, angelica sinensis, flos carthami, radix angelicae pubescentis, honeycomb, cortex eucommiae and semen momordicae. The medicinal plaster A and the medicinal plaster B are alternately applied while the two plasters are utilized. The traditional Chinese medicine preparation can also be prepared into various doses of medicinal plasters, ointments and externally-applied medicinal oils, and can be brewed into the medicinal liquor after being slightly adjusted or decocted to a decoction for oral administration. The invention has the following beneficial effects: the traditional Chinese medicine preparation is utilized to treat the diseases, such as osteoproliferation, osteoarthritis and degenerative osteoarthritis, and has the characteristics of being remarkable in efficacy, stable in effect, long in storage period, unlikely to relapse, flexible to prepare, convenient to use and taking effect quickly.

The invention provides a pharmaceutical composition for treating rhinitis, which is a preparation prepared from the following raw medicines in parts by weight: 12-18 parts of agastache rugosus, 15-25 parts of radix scrophulariae, 6-12 parts of magnolia flower, 7-13 parts of radix rubiae, 9-15 parts of thunberg fritillary bulb, 6-12 parts of radix bupleuri, 7-13 parts of angelica sinensis, 12-18 parts of uncaria rhynchophylla, 12-18 parts of mint, 12-18 parts of loofah sponge, 12-18 parts of honeysuckle stem, 5-11 parts of liquorice, 7-13 parts of radix angelicae, 7-13 parts of lumbricus, 7-13 parts of pericarpium granati, 7-13 parts of fructus chebulae, 4-8 parts of periostracum cicada, 7-13 parts of astragalus membranaceus, 7-13 parts of black tenuifolia, 7-13 parts of dark plum, 7-13 parts of cynanchum paniculatum, 2-5 parts of cassia twig, 9-15 parts of radix paeoniae alba, 4-8 parts of nidus vespae, 7-13 parts of radix arnebiae seu lithospermi, 7-13 parts of wild chrysanthemum flower, 15-25 parts of concha ostreae, 9-15 parts of schisandra chinensis, 12-18 parts of lesser duckweed, 7-13 parts of eclipta alba, 15-25 parts of momordica grosvenori and 7-13 parts of platycodon grandiflorum. The pharmaceutical composition disclosed by the invention can be used for effectively treating chronic allergic rhinitis, has the effects of eliminating or relieving symptoms such as rhinobyon, rhinocnesmus, much nasal mucus, clear nasal mucus, olfaction decline, headache or dizziness and the like caused by the rhinitis, also has a high total effective rate in treatment and provides a new choice for clinical medication.

The invention discloses a lumbricus peptide capable of resisting skin aging as well as a preparation method and an application thereof. The preparation method comprises the following steps: hydrolyzing an earthworm sample liquid by using own enzyme or adding protease, then carrying out membrane filtration and membrane interception on the hydrolysate, and freezing and drying to acquire the lumbricus peptide which can be applied to cosmetics or health care products capable of resisting skin aging. By the way, the preparation method is green and simple, and the prepared lumbricus peptide has the advantages of strong affinity, high safety, obvious antioxidant activity and capabilities of effectively promoting growth and multiplication of human skin fibroblast, significantly promoting secretion and synthesis of cell matrix collagen and obviously resisting skin aging and can be applied to the development of cosmetics and health care products capable of resisting skin aging.

The invention discloses a medicinal composition for treating ischemic stroke. The medicinal composition comprises one or more of Radix Astragali, Chinese angelica, Eucommia ulmoides, Panax Notoginseng, radix paeoniae rubra, Ligusticum wallichii, Salvia miltiorrhiza and safflower in Sichuan, and one or more of Gambir Plant, rhizoma gastrodiae, cassia seed, Gentiana macrophylla, lumbricus, scorpion and centipede. The traditional Chinese medicinal composition can improve ischemic damaged brain tissue structure, reduces intercellular substance oedema, substantially reduces the level of TNF-alpha and ICAM-1, has an anti-cerebral ischemia damage effect, has the efficacies of blood stasis removing, tissue regeneration promoting, endogenous wind calming and vein relaxing, can substantially reduce the hemiplegia rate and mortality of thrombus hemiplegia, and also can substantially improve acute blood stasis.

The invention relates to traditional Chinese medicine for treatment of cerebral hemorrhage. The traditional Chinese medicine comprises the following components in parts by weight: 50 parts of astragali radix, 30 parts of lumbricus, 30 parts of loofah sponge, 20 parts of ramulus mori, 20 parts of Chinese angelica, 25 parts of ligusticum wallichii, 30 parts of radix paeoniae rubra, 15 parts of radix bupleuri, 20 parts of oriental wormwood, 30 parts of peach kernel, 20 parts of safflower carthamus, 15 parts of radix angelicae, 15 parts of rhizoma cyperi, 20 parts of frankincense, 20 parts of myrrh and 10 parts of Chinese date. The traditional Chinese medicine for treatment of cerebral hemorrhage has no toxic Chinese herbal medicinal ingredients, has no toxic side effects, is low in cost, and can be used for treatment of various cerebral hemorrhage with the course of treatment for about 20 to 30 days, the curative effect is good, the effective rate reaches 100%, and the cure rate is more than 90%.

The invention discloses a traditional Chinese medicinal composition for treating breast cancer. In the traditional Chinese medicinal composition, the oral medicament is prepared from white peony root, pilose asiabell root, astragalus root, angelica, rhizoma drynariae, spica prunellae, radix gentianae, lithosperm root, rhizoma atractylodis macrocephalae, gamboges, scorpion, Tuckahoe, lumbricus, Chinese sage herb, fructus psoraleae, frankincense, nutgrass galingale rhizome and rhizoma paridis; and the external medicine is prepared from arisaema tuber, red sage root, prepared kusnezoff monkshood root, dahurian patrinia herb, suberect spatholobus stem, giant typhonium rhizome, frankincense, myrrh, szechuan lovage rhizome, mongolian dandelion herb, dahurian angelica, scorpion and ginger. The traditional Chinese medicinal composition has the advantages of strong targeting property with direct access to affected parts, low cost and the like, and is convenient for administration and manufacture. The traditional Chinese medicinal composition has the beneficial effects that traditional Chinese medicinal materials with different medicine properties are scientifically combined so as to reach ideal and safe therapeutic effect; by adopting oral and external administration modes, antitumor function can be realized, mammary tumor cells are eliminated and bone metastasis is inhibited, thus improving symptoms of a patient maximally, enhancing life quality and prolonging life; and the composition has low cost and is convenient to use, thus creating higher social value and higher economic benefit.

The invention relates to a feed for selenium-enriched beef cattle and a raising method of the selenium-enriched beef cattle. The feed is made from selenium-enriched medicago sativa, corn, barley, bran, sorghum, peanut cakes, zeolite powder, baking soda, stone powder, table salt, licorice roots, bighead atractylodes rhizomes, Chinese pulsatilla roots, lumbricus, radix codonopsis, Chinese magnoliavine fruits, radix ophiopogonis, radix astragali, haws, radix angelica sinensis, radix rehmanniae preparata, rhizoma ligustici wallichii, white peony roots, dried orange peel, poria cocos and the like. The feed is mixed with a crude feed in the weight ratio of the feed to the crude feed being 1 to 3 so as to obtain a mixture, wherein the daily feeding quantity of the feed is 1.5% of the body weight of the beef cattle, then the mixture is put for feeding the beef cattle for 42-70 days before the beef cattle become full-grown and ready for slaughter, and the selenium-enriched beef is produced. According to the feed, Chinese herbal medicines which can have a synergistic reaction are in reasonable compatibility, so that the immunocompetence of the beef cattle can be enhanced, stress response is eliminated, the transformation of nutrient components of the feed is promoted, the transformation efficiency of the feed is improved, the feed conversion rate is reduced, the daily gain of the beef cattle is increased, and the quality of the beef can also be greatly improved (the meat quality is fresh, fragrant, resistant to aftertaste, rich in nutrient components and the like). The feed disclosed by the invention is used for producing the selenium-enriched beef, and the production method is safe, low in cost and simple in technology.